AMPH Earnings

Quarterly EPS
$0.83
Q3 2024
$0.89
Q4 2024
$0.53
Q1 2025
$0.66
Q2 2025
$0.38
Q3 2025
$0.53
Q4 2025
$0.14
Q1 2026
$0.69
Q2 2026
Latest Revenue183.9M
Latest Net Income30.3M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.69183.9M30.3M+5.4%+4.5%
Q1 2026$0.14171.2M6.4M+0.4%-73.6%
Q4 2025$0.53183.1M24.4M-1.8%-40.4%
Q3 2025$0.38191.8M17.4M+0.3%-54.2%
Q2 2025$0.66174.4M31.0M-4.4%-14.3%
Q1 2025$0.53170.5M25.3M-0.8%-41.1%
Q4 2024$0.89186.5M38.0M+4.7%+18.7%
Q3 2024$0.83191.2M40.4M+5.9%-17.8%
Q2 2024$0.77182.4M37.9M
Q1 2024$0.90171.8M43.2M
Q4 2023$0.75178.1M36.2M
Q3 2023$1.01180.6M49.2M
Amphastar Pharmaceuticals (AMPH) — Earnings